Taiwan Liposome Company
Sheue Fang Shih Ph.D. Senior Director, Product Development Dr. Shih joined TLC in 2002. Dr. Shih has more than 15 years of experience in drug development. Her research focuses on the development of protein drug delivery, antibody discovery and targeted drug delivery with immunoliposomes. In her role as Manager/Project Leader, Dr. Shih led various research and development programs in areas of retinal diseases and arthritis and received IND approvals from the U.S. FDA as well as Taiwan FDA. Her current role specializes in drug development, product development strategy, non-clinical and clinical operations as well as planning. Dr. Shih has authored a number of scientific publications and is the inventor of a novel anti-VEGF antibody and several drug delivery patents. Dr. Shih received her Ph.D. and completed postdoctoral research from the Department of Biochemistry at National Taiwan University’s College of Medicine.
Pharma, Clinical research, Pharmaceutical sciences